Cargando…
Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine
PURPOSE OF REVIEW: The purpose of this review is to discuss the available evidence and therapeutic considerations for intravenous drug therapy for refractory chronic migraine. RECENT FINDINGS: In carefully monitored settings, the inpatient administration of intravenous lidocaine and ketamine can be...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665315/ https://www.ncbi.nlm.nih.gov/pubmed/34894295 http://dx.doi.org/10.1007/s11916-021-00992-x |
_version_ | 1784613982392287232 |
---|---|
author | Mojica, Jeffrey J. Schwenk, Eric S. Lauritsen, Clinton Nahas, Stephanie J. |
author_facet | Mojica, Jeffrey J. Schwenk, Eric S. Lauritsen, Clinton Nahas, Stephanie J. |
author_sort | Mojica, Jeffrey J. |
collection | PubMed |
description | PURPOSE OF REVIEW: The purpose of this review is to discuss the available evidence and therapeutic considerations for intravenous drug therapy for refractory chronic migraine. RECENT FINDINGS: In carefully monitored settings, the inpatient administration of intravenous lidocaine and ketamine can be successful in treating refractory chronic migraine. SUMMARY: Many patients with refractory chronic migraine have experienced treatment failure with the Raskin protocol. The use of aggressive inpatient infusion therapy consisting of intravenous lidocaine or ketamine, along with other adjunctive medications, has become increasingly common for these patients when all other treatments have failed. There is a clear need for prospective studies in this population comprised of patients who have largely been excluded from other studies. |
format | Online Article Text |
id | pubmed-8665315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-86653152021-12-14 Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine Mojica, Jeffrey J. Schwenk, Eric S. Lauritsen, Clinton Nahas, Stephanie J. Curr Pain Headache Rep Anesthetic Techniques in Pain Management (D Wang, Section Editor) PURPOSE OF REVIEW: The purpose of this review is to discuss the available evidence and therapeutic considerations for intravenous drug therapy for refractory chronic migraine. RECENT FINDINGS: In carefully monitored settings, the inpatient administration of intravenous lidocaine and ketamine can be successful in treating refractory chronic migraine. SUMMARY: Many patients with refractory chronic migraine have experienced treatment failure with the Raskin protocol. The use of aggressive inpatient infusion therapy consisting of intravenous lidocaine or ketamine, along with other adjunctive medications, has become increasingly common for these patients when all other treatments have failed. There is a clear need for prospective studies in this population comprised of patients who have largely been excluded from other studies. Springer US 2021-12-11 2021 /pmc/articles/PMC8665315/ /pubmed/34894295 http://dx.doi.org/10.1007/s11916-021-00992-x Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Anesthetic Techniques in Pain Management (D Wang, Section Editor) Mojica, Jeffrey J. Schwenk, Eric S. Lauritsen, Clinton Nahas, Stephanie J. Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine |
title | Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine |
title_full | Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine |
title_fullStr | Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine |
title_full_unstemmed | Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine |
title_short | Beyond the Raskin Protocol: Ketamine, Lidocaine, and Other Therapies for Refractory Chronic Migraine |
title_sort | beyond the raskin protocol: ketamine, lidocaine, and other therapies for refractory chronic migraine |
topic | Anesthetic Techniques in Pain Management (D Wang, Section Editor) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665315/ https://www.ncbi.nlm.nih.gov/pubmed/34894295 http://dx.doi.org/10.1007/s11916-021-00992-x |
work_keys_str_mv | AT mojicajeffreyj beyondtheraskinprotocolketaminelidocaineandothertherapiesforrefractorychronicmigraine AT schwenkerics beyondtheraskinprotocolketaminelidocaineandothertherapiesforrefractorychronicmigraine AT lauritsenclinton beyondtheraskinprotocolketaminelidocaineandothertherapiesforrefractorychronicmigraine AT nahasstephaniej beyondtheraskinprotocolketaminelidocaineandothertherapiesforrefractorychronicmigraine |